Standard Drug Panels for the Different Tumor Types*

The treating physician can choose for patients on the Laboratory Service Requisition Formpdficon_small.png standard drug panels according to the patients‘ tumor types and/or he can create his own customer specifc drug panels. There are at least 33 validated drugs available and more drugs will be added in the future. The physician has the option to get tested either up to 7 drugs (or drug combinations) or up to 14 drugs (or drug combinations).


Cervical CA

Colorectal CA

Endometrial CA

Glioma

  1. Cisplatin
  2. Ifosfamide
  3. Vinblastine
  4. Paclitaxel
  5. Topotecan
  6. Doxorubicin
  7. Fluorouracil
  1. Fluorouracil
  2. Irinotecan
  3. Fluorouracil + Irinotecan
  4. Oxaliplatin
  5. Topotecan
  6. Capecitabine
  7. Floxuridin
  1. Cisplatin
  2. Paclitaxel
  3. Doxorubicin
  4. Ifosfamide
  5. Etoposide
  6. Cyclophosphamide
  7. Topotecan
  1. Temozolomide
  2. Carmustine
  3. Cisplatin
  4. Cyclophosphamide
  5. Vincristine
  6. Doxorubicin
  7. Etoposide

Lung CA
(non-small cell, NSCLC)

Mamma CA

Melanoma

Ovarian CA

  1. Cisplatin
  2. Paclitaxel
  3. Vinorelbine
  4. Etoposide
  5. Gemcitabine
  6. Topotecan
  7. Carboplatin
  1. Fluorouracil
  2. Epirubicin
  3. Cyclophosphamide
  4. Docetaxel
  5. Paclitaxel
  6. Vinorelbine
  7. Doxorubicin
  1. Cisplatin
  2. Temozolomide
  3. Vinblastine
  4. Docetaxel
  5. Vinorelbine
  6. Gemcitabine
  7. Vinorelbine + Docetaxel
  1. Carboplatin
  2. Paclitaxel
  3. Topotecan
  4. Doxorubicin (liposomal)
  5. Etoposide
  6. Gemcitabine
  7. Carboplatin + Paclitaxel

Pancreatic CA

Sarcoma

Stomach/Gastric CA
(non colorectal)

Unknown Origin

  1. Gemcitabine
  2. Fluorouracil
  3. Ifosfamide
  4. Doxorubicin
  5. Irinotecan
  6. Mitomycin C
  7. Docetaxel
  1. Doxorubicin
  2. Ifosfamide
  3. Temozolomide
  4. Cisplatin
  5. Docetaxel
  6. Gemcitabine
  7. Topotecan
  1. Fluorouracil
  2. Mitomycin C
  3. Doxorubicin
  4. Cisplatin
  5. Etoposide
  6. Gemcitabine
  7. Paclitaxel
  1. Cisplatin
  2. Doxorubicin
  3. Fluorouracil
  4. Cyclophosphamide
  5. Paclitaxel
  6. Topotecan
  7. Etoposide

* Standard drug panels are reviewed frequently and are subject to change.



Customer Specific Drug Panel

Drugs, which are validated for CTR-Test® and can be tested, are listed below. The drugs can be selected in the customer specific drug panel either as single drugs or as combinations.

Substance name

Brand name (extract)

Actinomycin D

Actinomycin

Bleomycin

BLEO-cell, Bleomedac, Bleo-cell

Capecitabine

Xeloda

Carboplatin

Carbomedac, Ribocarbo-L, Carboplat

Carmustine

Carmubris, Gliadel

Cisplatin

Cis-GRY, Platiblastin, Platinol

Cyclophosphamide

Endoxan

Cytarabine

Alexan, ARA-cell, Cytosar, DepoCyte

Dacarbazin

Dacin, Detimedac

Docetaxel

Taxotere

Doxorubicin

Adriblastin, Adrimedac, Ribodoxo

Doxorubicin (liposomal)

Myocet, Caelyx, Doxil

Epirubicine

Axirubicin-e, Epi-cell, Farmorubicin

Etoposide

Eto-cell, Etomedac, Riboposid, Vepesid

Floxuridin

Floxuridin,FUDR

Fluorouracil, 5-FU

Benda-5 FU, Efudix, Neofluor, Onkofluor

Gemcitabine

Cytogembin, Gemcapyr, Gemzar

Ifosfamide

Holoxan, IFO-cell

Imatinib

Glivec

Irinotecan

Arinotec, Axinotecan, Campto, Camptosar

Melphalan

Alkeran

Mitomycin C

Amétycine, Urocin, Mito-medac

Mitoxantron

Ebexantron, Novantron, Ralenova

Oxaliplatin

Bendaplatin, Croloxat, Eloxatin, Medoxa

Paclitaxel

Albraxane, Paxene, Ribotax, Taxol

Tamoxifen

Mandofen, Nolvadex, Tamokadin

Temozolomide

Temodal

Topotecan

Hycamtin

Trabectedin

Yondelis

Treosulfan

Ovastat

Vinblastine

Cellblastin, Velbe, Vinblastinsulfat-GRY

Vincristine

Cellcristin, FARMISTIN, Onkocristin

Vinorelbine

Bendarelbin, Navelbine, Navin, Vinocleus


Just call us:

Monday to Thursday from 9:00 - 16:00
and Friday from 9:00 - 15:00

Our phone number:
+49 6221-8936-157

Send us a message:

We will get back to you as soon as possible.
Your TherapySelect Team


Our Awards

Award for innovative research
Award from the Federal Ministry of Education and Research, Germany
Award from the Federal Ministry for Economic Affairs and Energy of Germany
Award from the European Union